首页> 外文期刊>Cardiovascular revascularization medicine: including molecular interventions >Does micropuncture technique really help reduce vascular complications?
【24h】

Does micropuncture technique really help reduce vascular complications?

机译:微直流技术是否真的有助于降低血管并发症?

获取原文
获取原文并翻译 | 示例
           

摘要

BackgroundMicropuncture technique (MPT) is being adapted nationally to reduce vascular complications (VC). We initiated a quality improvement project in our cath lab to reduce VCs utilizing MPT. MethodsWe utilized MPT on all of our non-STEMI femoral artery (FA) access cases starting September 2016. As a comparator group, we collected data from April to August 2016. Anatomic localization of FA and fluoroscopic marking of femoral head was utilized in all cases. VCs were defined by BARC definitions for bleeding/hematomas, retroperitoneal bleed, pseudoaneurysm, AV fistula, arterial thrombosis, distal embolism, dissection, and transient limb ischemia. ResultsA total of 647 patients (Male 357, Female 290; MPT 333) were included in the analysis. MPT as compared to regular 18-gauge needle access did not demonstrate a reduction in VCs (2.4% vs. 2.2%;p?=?1.0). MPT utilization did not affect the risk of VCs on univariate (OR 1.08; 95% CI 0.38–3.01;p?=?0.88) or multivariate analysis (OR 0.91, 95% CI 0.28–2.93; p?+?0.87). Vascular closure device (VCD) utilization as compared to manual/fem-stop hemostasis was the only factor that demonstrated a statistically significant and lower VC rate on both univariate (OR 0.28; 95% CI: 0.08–0.89;p?=?0.03), and multivariate (OR 0.24; 95% CI 0.06–0.93;p?=?0.039) analysis. ConclusionUtilization of MPT in conjunction with fluoroscopic marking of the femoral head and without ultrasound guidance did not contribute to statistically significant reduction in the VC rate. The only factor found to be beneficial is utilization of VCDs. Further large randomized studies are required to demonstrate benefit of routinely utilizing MPT.
机译:背景技术(MPT)正在全国调整以减少血管并发症(VC)。我们在CANT实验室启动了一个质量改进项目,以减少利用MPT的VCS。方法网络在2016年9月开始的所有非Stemi股动脉(FA)接入案件上使用MPT。作为比较组,我们从4月到2016年4月收集了数据。所有病例都使用了股骨头的FA和荧光透视标记的解剖学定位。 VCS由BARC定义为出血/血肿,腹膜后渗流,假血管肌瘤,AV瘘,动脉血栓形成,远端栓塞,解剖和瞬态肢体缺血。结果总共647名患者(男性357,女性290; MPT 333)均被纳入分析。与常规18号针头接入相比,MPT没有证明VCS的减少(2.4%与2.2%; p?=?1.0)。 MPT利用率不会影响单变量(或1.08; 95%CI 0.38-3.01; p?= 0.88)或多变量分析(或0.91,95%CI 0.28-2.93; p?+ 0.87)上的VCS上的风险与手动/ FEM-STOP止血相比,血管闭合装置(VCD)利用是在单变量(或0.28; 95%CI:0.08-0.89; P?= 0.03)上表现出统计上显着和更低的VC速率的唯一因素,多元(或0.24; 95%CI 0.06-0.93; p?= 0.039)分析。结论MPT与股骨头荧光透视和无超声引导结合的混合物的硫化在VC速率下没有有助于统计上显着降低。发现有益的唯一因素是利用VCD。需要进一步大的随机研究来证明常规使用MPT的效益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号